PL1682098T3 - Kompozycja środka przeczyszczającego okrężnicę z rozpuszczalnym czynnikiem wiążącym - Google Patents

Kompozycja środka przeczyszczającego okrężnicę z rozpuszczalnym czynnikiem wiążącym

Info

Publication number
PL1682098T3
PL1682098T3 PL04819530.9T PL04819530T PL1682098T3 PL 1682098 T3 PL1682098 T3 PL 1682098T3 PL 04819530 T PL04819530 T PL 04819530T PL 1682098 T3 PL1682098 T3 PL 1682098T3
Authority
PL
Poland
Prior art keywords
binding agent
soluble binding
colonic purgative
purgative composition
composition
Prior art date
Application number
PL04819530.9T
Other languages
English (en)
Inventor
Stephen Skiendzielewski
Martin Rose
Ngoc Do
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34632758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1682098(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL1682098T3 publication Critical patent/PL1682098T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL04819530.9T 2003-11-19 2004-11-17 Kompozycja środka przeczyszczającego okrężnicę z rozpuszczalnym czynnikiem wiążącym PL1682098T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52314203P 2003-11-19 2003-11-19

Publications (1)

Publication Number Publication Date
PL1682098T3 true PL1682098T3 (pl) 2016-11-30

Family

ID=34632758

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04819530.9T PL1682098T3 (pl) 2003-11-19 2004-11-17 Kompozycja środka przeczyszczającego okrężnicę z rozpuszczalnym czynnikiem wiążącym

Country Status (12)

Country Link
US (3) US7687075B2 (pl)
EP (2) EP1682098B1 (pl)
JP (3) JP5329042B2 (pl)
KR (4) KR101495690B1 (pl)
CN (2) CN101087593B (pl)
AR (1) AR046651A1 (pl)
AU (2) AU2004292428B2 (pl)
BR (2) BRPI0416702B8 (pl)
CA (2) CA2814523C (pl)
ES (1) ES2584866T3 (pl)
PL (1) PL1682098T3 (pl)
WO (1) WO2005051361A1 (pl)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
KR20080030549A (ko) * 2004-12-30 2008-04-04 기븐 이미징 리미티드 체내 검사를 위한 장치, 시스템 및 방법
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
AU2013202513B2 (en) * 2005-05-06 2016-03-24 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
CN1748675A (zh) * 2005-07-11 2006-03-22 丛晓东 大黄酸类化合物的复合物及制备方法与治疗糖尿病的应用
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
BRPI0709472A2 (pt) 2006-04-07 2011-07-12 Sunten Phytotech Co Ltd "composição farmacêutica, composição dietética e uso da composição
DE102006017672B4 (de) * 2006-04-12 2008-07-03 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Verwendung als Laxativum
ES2292345B1 (es) * 2006-05-12 2009-02-16 Madaus, S.A. "uso, composicion y preparacion farmaceutica de plantago ovata".
DE102007023397B4 (de) * 2007-05-02 2015-03-26 Madaus Gmbh Neue pharmazeutische Zusammensetzung zur Verwendung als Laxativum
WO2008143916A2 (en) * 2007-05-17 2008-11-27 Theravance, Inc. Prokinetic agent for bowel preparation
AU2008253583A1 (en) * 2007-05-17 2008-11-27 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
CN101450049A (zh) * 2007-12-07 2009-06-10 辉凌国际制药（瑞士）有限公司 药物组合物
SI2294012T1 (sl) * 2008-05-07 2014-11-28 Salix Pharmaceuticals, Ltd. Dajanje ÄŤistila za ÄŤrevo in antibiotika za zdravljenje ÄŤrevesne bolezni
WO2010005965A1 (en) * 2008-07-08 2010-01-14 Aronchick Craig A Colonic purgative formulations and methods of using the same
KR101053731B1 (ko) * 2008-10-21 2011-08-02 이문성 용해시간 조절형 장세척제 조성물의 제조방법
US20100178360A1 (en) * 2009-01-13 2010-07-15 Universite Libre De Bruxelles Nutritive composition
CN102481316A (zh) * 2009-03-27 2012-05-30 萨利克斯药品有限公司 用于肠道制剂的组合物及其使用方法
LT2421373T (lt) * 2009-04-21 2020-01-10 Dale R. Bachwich Gaubtinės žarnos lavažo sistema
CN101874796A (zh) * 2009-04-29 2010-11-03 田普森 一种治疗便秘的药物制剂及其制备方法
WO2010141751A1 (en) * 2009-06-03 2010-12-09 Axcan Pharma Inc. L-sugar colon cleansing agent and uses thereof
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110021591A1 (en) * 2009-07-21 2011-01-27 Gordon Douglas J Phenylbutazone carrier formulation showing increased bioactivity in animals
JP5605365B2 (ja) * 2009-08-31 2014-10-15 ゼリア新薬工業株式会社 経口腸管洗浄用錠剤
WO2011047178A1 (en) * 2009-10-14 2011-04-21 Gi Innovation, Pllc Colon cleansing of residual stool and secretions during colonoscopy
WO2011050397A1 (en) * 2009-10-26 2011-05-05 Borody Thomas J Novel enteric combination therapy
CN102283861A (zh) * 2010-06-17 2011-12-21 杭州赛利药物研究所有限公司 氢氧化镁在制药中的用途以及氢氧化镁制剂和制备方法
BR112013014827A2 (pt) * 2010-12-13 2016-10-04 Antony Wettstein formulações gástricas e colônicas e métodos para produzir e usar as mesmas
CN103391790B (zh) 2011-01-28 2016-06-15 布伦特里实验室有限公司 用于肠道清洁的方法、组合物以及包装
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
US8778907B2 (en) 2011-04-27 2014-07-15 Cumberland Pharmaceuticals Lactulose for bowel evacuation
CN102178694B (zh) * 2011-05-06 2013-03-20 四川健能制药有限公司 磷酸钠盐液体制剂
JP5842521B2 (ja) * 2011-09-30 2016-01-13 ゼリア新薬工業株式会社 便秘改善薬
JP6240610B2 (ja) * 2011-10-27 2017-11-29 サリックス ファーマシューティカルズ，インコーポレイテッド 電解質下剤
RU2473330C1 (ru) * 2011-12-09 2013-01-27 Александр Павлович Погромов Средство для кишечного лаважа
WO2014016671A2 (en) 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
KR20210063445A (ko) 2012-09-11 2021-06-01 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
PT2968174T (pt) 2013-03-15 2020-01-15 Braintree Laboratories Inc Comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e seus métodos de utilização
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤
CN103585173B (zh) * 2013-10-28 2016-06-29 王显著 含硫酸钠和匹可硫酸的药物组合物
KR101659746B1 (ko) * 2014-01-28 2016-09-26 주식회사한국파마 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법
CA2947434A1 (en) 2014-04-29 2015-11-05 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
WO2016140981A1 (en) 2015-03-02 2016-09-09 Colonaryconcepts Llc Compounds and methods for peg metabolite and peg breakdown product assays
EP3311814A4 (en) * 2015-06-22 2019-02-27 CTC Bio, Inc. DISCHARGE COMPOSITION FOR CLEANING THE DARMTRACT
WO2017011430A1 (en) * 2015-07-13 2017-01-19 Halow George M Bowel cleansing compositions and methods
KR101811032B1 (ko) * 2016-01-28 2017-12-20 주식회사 씨티씨바이오 하제 조성물
JP2018131396A (ja) * 2017-02-14 2018-08-23 学校法人自治医科大学 経口腸管洗浄剤および大腸カプセル内視鏡用ブースター
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR102005072B1 (ko) * 2017-12-15 2019-07-29 주식회사 씨티씨바이오 장관 세척용 하제 조성물
KR102111094B1 (ko) 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물
CN112386577B (zh) * 2019-08-16 2024-01-23 北京天衡药物研究院有限公司 一种治疗便秘的组合物
CN112587498A (zh) * 2020-12-29 2021-04-02 哈尔滨瀚钧现代制药有限公司 多库酯钠丹蒽醌及其制备方法
CN115040512B (zh) * 2022-07-28 2023-06-20 苏州中化药品工业有限公司 一种药物组合物及其制备方法
WO2024149252A1 (zh) * 2023-01-09 2024-07-18 上海石趣医药科技有限公司 磷酸镁物质、包含其的药物组合物及其用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) * 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US3202578A (en) * 1957-09-27 1965-08-24 Elder Paul B Co Polymeric laxative composition and method of using same
GB1459488A (en) * 1974-03-19 1976-12-22 Wyeth John & Brother Ltd Piperazinedione derivatives
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4812311A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Kit for use in the treatment of osteoporosis
EP0231356A1 (en) 1985-08-01 1987-08-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US4828842A (en) * 1986-09-16 1989-05-09 L. Perrigo Company Water dispersible compound
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
JPH0816061B2 (ja) * 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
US5294451A (en) * 1991-03-29 1994-03-15 Curtice-Burns, Inc. Fat substitute compositions having reduced laxative effects
US5397573A (en) * 1993-06-04 1995-03-14 The Procter & Gamble Company Laxative compositions
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
US5498425A (en) * 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
FR2746643B1 (fr) * 1996-04-01 1998-06-12 Techni Pharma Nouvelles compositions laxatives et leur procede de fabrication
DK0858326T3 (da) * 1996-05-08 2003-07-07 Craig A Aronchick Ikke-vandige colonafføringsmidler
SI0872242T1 (en) * 1996-11-13 2001-12-31 Cb Fleet Co Inc A coated sodium phosphate bowel cleanser
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US6645481B1 (en) 2000-09-28 2003-11-11 Braintree Laboratories, Inc. Method of achieving overnight laxation and control of bowel function
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US8361452B2 (en) 2002-07-15 2013-01-29 Halow George M Bowel cleansing composition
US20040071779A1 (en) 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent

Also Published As

Publication number Publication date
US20080213393A1 (en) 2008-09-04
JP2007512336A (ja) 2007-05-17
BRPI0416702B1 (pt) 2020-10-20
BR122014001142B1 (pt) 2018-10-30
EP1682098A1 (en) 2006-07-26
AU2004292428B2 (en) 2011-06-02
US7687075B2 (en) 2010-03-30
JP2014065746A (ja) 2014-04-17
ES2584866T3 (es) 2016-09-29
AU2004292428A1 (en) 2005-06-09
BRPI0416702A8 (pt) 2020-09-24
CA2814523C (en) 2016-01-12
AR046651A1 (es) 2005-12-14
CN101087593A (zh) 2007-12-12
US7718197B2 (en) 2010-05-18
BR122014001142A2 (pt) 2015-08-18
JP2011173933A (ja) 2011-09-08
CN101087593B (zh) 2013-07-17
CA2546637C (en) 2013-06-18
KR20110098015A (ko) 2011-08-31
JP5502807B2 (ja) 2014-05-28
EP1682098B1 (en) 2016-05-25
CA2814523A1 (en) 2005-06-09
EP2308476B1 (en) 2016-12-14
KR20120045015A (ko) 2012-05-08
BR122014001142B8 (pt) 2021-05-25
AU2011202346A1 (en) 2011-06-16
CN102648980B (zh) 2016-08-31
AU2011202346B2 (en) 2012-05-24
KR20060114342A (ko) 2006-11-06
CN102648980A (zh) 2012-08-29
WO2005051361A1 (en) 2005-06-09
JP5329042B2 (ja) 2013-10-30
EP2308476A1 (en) 2011-04-13
BRPI0416702A2 (pt) 2015-01-27
KR101323628B1 (ko) 2013-11-01
KR101268559B1 (ko) 2013-05-31
US8507009B2 (en) 2013-08-13
US20050129781A1 (en) 2005-06-16
CA2546637A1 (en) 2005-06-09
BRPI0416702B8 (pt) 2022-08-23
KR101495690B1 (ko) 2015-02-25
US20100159026A1 (en) 2010-06-24
KR20130048790A (ko) 2013-05-10

Similar Documents

Publication Publication Date Title
PL1682098T3 (pl) Kompozycja środka przeczyszczającego okrężnicę z rozpuszczalnym czynnikiem wiążącym
IL186944A0 (en) Polyethylene glycol colonic purgative composition
HRP20180420T1 (hr) U vodi topljivi filmovi koji sadrže niskoviskozne alginate
IL182279A0 (en) Angiopoietin-2-specific binding agents
EP1676582A4 (en) AGENT CONTROLLING CORONAVIRUS
GB0404187D0 (en) Binding agents
GB0302738D0 (en) Composition
PL1641900T5 (pl) Kompozycja benzynowa
HUE041365T2 (hu) Demodikózis elleni szer
EP1622572A4 (en) CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY
GB0305989D0 (en) Agent
GB0324897D0 (en) Composition
GB0322033D0 (en) Composition
GB0310365D0 (en) Polymeric composition
PT1663273E (pt) Composição na forma de pó para utilização como laxante
GB0312345D0 (en) Improvements in compositions
GB0321802D0 (en) Soluble compounds
GB0416138D0 (en) Anti cancer agent
GB0324168D0 (en) Composition II
GB0323203D0 (en) Composition II
GB0309017D0 (en) Improved polymer composition
PL368096A1 (pl) Środek zwilżająco-piorący
EP1712219A4 (en) AGENT DECREASING WRINKLES
HU0300932D0 (en) Sexualhigienie composition
GB0320863D0 (en) Composition